453 related articles for article (PubMed ID: 21365951)
1. [Mycophenolate mofetil for the treatment of lupus nephritis. The case of lupus nephritis--class IV according to WHO--treated with mycophenolate mofetil].
Suszek D; Wielosz E; Majdan M
Ann Acad Med Stetin; 2010; 56 Suppl 1():91-4. PubMed ID: 21365951
[TBL] [Abstract][Full Text] [Related]
2. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy.
Nawata T; Kubo M; Fujii S; Shiragami K; Ikegami T; Kobayashi S; Hisano S; Yano M
Intern Med; 2018 Jul; 57(14):2067-2070. PubMed ID: 29491296
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
Lanata CM; Mahmood T; Fine DM; Petri M
Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis.
Walsh M; James M; Jayne D; Tonelli M; Manns BJ; Hemmelgarn BR
Clin J Am Soc Nephrol; 2007 Sep; 2(5):968-75. PubMed ID: 17702723
[TBL] [Abstract][Full Text] [Related]
8. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
9. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
[TBL] [Abstract][Full Text] [Related]
10. [Mycophenolate mofetil in lupus nephritis].
Alvarez L; Rivera F; Gil CM; Jiménez del Cerro LA; Olivares J
Nefrologia; 2002; 22(1):24-32. PubMed ID: 11987681
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.
Liu LL; Jiang Y; Wang LN; Yao L; Li ZL
Drugs; 2012 Jul; 72(11):1521-33. PubMed ID: 22818016
[TBL] [Abstract][Full Text] [Related]
12. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
Lau KK; Ault BH; Jones DP; Butani L
J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
[TBL] [Abstract][Full Text] [Related]
13. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?
Hogan J; Schwenk MH; Radhakrishnan J
Kidney Int; 2012 Dec; 82(12):1256-60. PubMed ID: 22648298
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
[TBL] [Abstract][Full Text] [Related]
16. Late recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil.
Ahuja TS; Boughton J; Weiss V; Memon A; Remmers A; Rajaraman S
Am J Med Sci; 2001 Sep; 322(3):166-9. PubMed ID: 11570784
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.
Laskari K; Mavragani CP; Tzioufas AG; Moutsopoulos HM
Arthritis Res Ther; 2010; 12(6):R208. PubMed ID: 21059275
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological therapy of lupus nephritis.
Fine DM
JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568
[TBL] [Abstract][Full Text] [Related]
20. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
